Factory Low Price Soft Shell Hyperbaric Chamber Chamber Hbot 1.5ATA for Ddiabetic Foot Therapy

Name: Factory Low Price Soft Shell Hyperbaric Chamber Chamber Hbot 1.5ATA for Ddiabetic Foot Therapy
Brand: Nanjing Kingshare Biotechnology Co., Ltd.
SKU: 1976682891

Jiangsu, ChinaNanjing Kingshare Biotechnology Co., Ltd.

US$1,699.00-3,599.00

1 Set

Product profile

Customization

Available

Type

Health Use

Function

Improve Blood Circulation

Model NO.

KX-RU01

Theory

Health Use

Certification

CE, ISO13485, Ukca RoHS

LCD Display

Without LCD Display

Group

Adult and Child

Product Name

Soft Shell Hyperbaric Chamber Chamber Hbot

Application

Home Clinic SPA Gym Office Hospital

Pressure

1.5ATA

Oxygen Purity

95%

Flow Rate

10L

Material

TPU

Weight

30kg

Voltage

110/220V

Warranty

2 Year

Shelf Life

3 Year

MOQ

1 Set

After Sale Service

Online Technical Support

Transport Package

Pallet/Box

Specification

L1750*W800*H1320mm

Trademark

Kingshare

Origin

Jiangsu, China

Company profile

Standardized quality controlQuality AssuranceProduct CertificationFast Delivery

Nanjing Kingshare Biotechnology Co., Ltd.

Jiangsu, China

CertifiedBusiness Type: Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 3 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤2.87h

AI-Powered supplier vetting

SummaryKingShare Biotech is presented as a vertically integrated biotechnology solutions provider with more than 20 years of experience and its own manufacturing facility exceeding 5,000 square meters. It reports professional R&D capability, 3D software design, broad customization services, documented design controls, and technical support covering production and after-sales service. Production information includes annual output of 10,800 hyperbaric oxygen chamber sets, inventory capability, and standardized finished-product inspection instructions. However, only one QA/QC inspector is reported, and the supplier lacks overseas warehouses, showrooms, agents, or branches. Service-capability supplier management is weakly documented, with no written assessment procedures, approved-supplier list, or corrective/preventive-action records. Financial credibility cannot be favorably assessed because the provided financial data is zero-valued and incomplete. No certifications or customer cases are explicitly provided.

Supplier typeThe supplier identifies itself as a vertically integrated biotechnology solutions provider with its own manufacturing facility and global B2B sales models. Its stated business scope includes medical-device production and sales of separation, purification, and mechanical equipment, supporting classification as a manufacturer and technical solution supplier.

After-Sales capabilityTechnology engineers are responsible for technical support during production and after-sales service, indicating an internal after-sales support function. However, the supplier reports no overseas warehouse, showroom, agent, or branch capability, so overseas service coverage appears limited.

R&D capabilityThe supplier reports professional R&D capability, 3D software design, broad product-design services, technical engineers for new-product development, and available design input/output, review, verification, and validation documentation. No SDK is available, which limits software-development integration capability but does not negate the documented product R&D capability.

Production capacityThe supplier operates its own manufacturing facility exceeding 5,000 square meters, reports annual production of 10,800 hyperbaric oxygen chamber sets, and has in-stock service capability. Finished-product inspection follows documented and uniformly applied instructions, although only one QA/QC inspector is reported.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, minor customization, and flexible customization, supported by engineers who confirm customer requirements and design new products. The availability of design-control documentation further supports structured customization execution.